Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • Log out
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Molecular Cancer Research
Molecular Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

DNA Damage and Cellular Stress Responses

Uncoupling p53 Functions in Radiation-Induced Intestinal Damage via PUMA and p21

Brian J. Leibowitz, Wei Qiu, Hongtao Liu, Tao Cheng, Lin Zhang and Jian Yu
Brian J. Leibowitz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Qiu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hongtao Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tao Cheng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Zhang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jian Yu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1541-7786.MCR-11-0052 Published May 2011
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

The role of p53 in tissue protection is not well understood. Loss of p53 blocks apoptosis in the intestinal crypts following irradiation but paradoxically accelerates gastrointestinal (GI) damage and death. PUMA and p21 are the major mediators of p53-dependent apoptosis and cell-cycle checkpoints, respectively. To better understand these two arms of p53 response in radiation-induced GI damage, we compared animal survival, as well as apoptosis, proliferation, cell-cycle progression, DNA damage, and regeneration in the crypts of WT, p53 knockout (KO), PUMA KO, p21 KO, and p21/PUMA double KO (DKO) mice in a whole body irradiation model. Deficiency in p53 or p21 led to shortened survival but accelerated crypt regeneration associated with massive nonapoptotic cell death. Nonapoptotic cell death is characterized by aberrant cell-cycle progression, persistent DNA damage, rampant replication stress, and genome instability. PUMA deficiency alone enhanced survival and crypt regeneration by blocking apoptosis but failed to rescue delayed nonapoptotic crypt death or shortened survival in p21 KO mice. These studies help to better understand p53 functions in tissue injury and regeneration and to potentially improve strategies to protect or mitigate intestinal damage induced by radiation. Mol Cancer Res; 9(5); 616–25. ©2011 AACR.

Introduction

Exposure to high doses of radiation causes acute gastrointestinal (GI) injury, which is also a significant dose-limiting factor in abdominal and pelvic radiotherapy (1, 2). In contrast to the lethal hematopoietic (HP) injury developed from lower doses of irradiation, which can be rescued by bone marrow transplantation, there is no approved treatment or preventive measure for GI damage (3). Radiation models have been used extensively to understand the DNA damage response and stem cell biology (1, 4, 5). Rapidly renewing tissues, such as the GI epithelium, bone marrow, and hair follicles, undergo extensive apoptosis in response genotoxic stresses including radiation. Loss of p53 protects the hematopoietic system and skin against DNA damage–induced injuries (6, 7) but unexpectedly exacerbates GI damage despite blocked apoptosis (8–10).

Following genotoxic stress, p53 is stabilized and activates transcriptional programs to restrict inappropriate cell proliferation and maintain genome integrity (11, 12). p53-dependent induction of p21 or PUMA is required for p53-depedent cell-cycle arrest or apoptosis following ionizing radiation (IR) in most cell types (12, 13). p21 inhibits several cyclin-dependent kinases (CDK) to initiate the G1 cell-cycle checkpoint, and maintain the G2/M checkpoint in some cells (14). PUMA, a proapoptotic BH3-only Bcl-2 family protein, promotes Bax/Bak and mitochondria-dependent apoptosis in various cell types (15–19). Selective expression of apoptotic or cell-cycle regulators has been proposed as a mechanism in determining cell fate following DNA damage (12, 13). We and others have shown recently that PUMA deficiency improves survival and tissue regeneration following lethal doses of IR by blocking apoptosis in stem and progenitor cells of the small intestine and bone marrow, which is associated with elevated p21 levels (20–23).

We hypothesized that the paradoxical role of p53 in radiation-induced intestinal damage may be explained by its major downstream targets that regulate apoptosis and cell-cycle arrest independently. To test this hypothesis, we compared animal survival, as well as apoptosis, proliferation, cell-cycle progression, DNA damage, and regeneration in the crypts of WT, p53 knockout (KO), PUMA KO, p21 KO, and PUMA/p21 double KO (DKO) mice in a whole body irradiation (WBI) model. We found that deficiency in p53 or p21 leads to accelerated crypt regeneration but shortened survival, which is associated with massive nonapoptotic cell death resulting from aberrant proliferation of clonogenic cells with persistent DNA damage and genome instability. PUMA deficiency did not rescue delayed nonapoptotic crypt death or shortened survival in p21 KO mice, indicating that that a p21-dependent mechanism is required for the productive regeneration of crypts and improved survival in mice resistant to radiation-induced apoptosis.

Materials and Methods

Mice and treatment

The procedures for all animal experiments were approved by the Institutional Animal Care and Use Committee of the University of Pittsburgh. Seven- to 10-week-old PUMA+/+/p21+/+ (WT), PUMA−/− (PUMA KO; ref. 24), p21−/− (p21 KO; Jackson Laboratory), PUMA−/−/p21−/− (DKO), and p53−/− (p53 KO; Jackson Laboratory) mice were generated from heterozygote breeding. All strains are in or have been backcrossed with the C57BL/6 background for more than 10 generations (F10), and litter mates were used for PUMA KO, p21 KO, and PUMA/p21 DKO. Mice were housed in microisolator cages in a room illuminated from 7:00 AM to 7:00 PM (12:12-hour light–dark cycle), with access to water and chow ad libitum. Genotyping of WT, PUMA KO, and p53 KO (25) and p21 KO (26) alleles were conducted as described. Mice were irradiated at a rate of 76 cGy/min in a 137Cs irradiator (Mark I; JL Shepherd and Associates).

Western blotting

Antibodies used include those against PUMA (ab9643; Abcam), p53 and p21 (sc-6243 and sc-397; Santa Cruz Biotechnology), and actin (A5541; Sigma-Aldrich). Tissue lysates were collected from freshly scraped intestinal mucosa as previously described (25).

Tissue processing, histologic analysis, TUNEL and bromodeoxyuridine staining, and crypt microcolony assay

All mice were injected with 100 mg/kg bromodeoxyuridine (BrdU; Sigma-Aldrich) 2 hours before sacrifice. The intestinal tissues were harvested and processed in bundles as described (20, 27; Supplementary Material). Histologic analysis was conducted by hematoxylin and eosin (H&E) staining. Mitoses were scored by visual inspections of H&E sections under microscope at magnification of 600× (28). Normal mitoses contain condensed chromosomes that show even and symmetrical separation and alignment. Aberrant mitoses contain condensed chromosomes with multipolar spindles, lagging or misaligned chromosomes, anaphase bridges, or micronuclei.

TUNEL (terminal deoxynucleotidyl transferase–mediated dUTP nick end labeling) and BrdU staining were conducted as described (20; Supplementary Material). In brief, TUNEL staining was conducted with the ApopTag Peroxidase Kit or ApopTag Fluorescein In Situ Apoptosis Detection Kit (Chemicon International). Complete crypts extending to neighboring villi and containing at least 17 cells along either side with several Paneth cells at the bottom were used for counting in samples collected up to 48 hours after irradiation unless indicated otherwise. TUNEL- or BrdU-positive cells were scored in 100 crypts per mouse, with a minimum of 3 mice per group. Data were reported as means ± SEM.

The crypt microcolony assay was used to quantify stem cell survival by counting regenerated crypts in H&E-stained cross-sections 3 and 4 days postirradiation (20). More details are found in the Supplementary Material. At least 3 mice were used in each group and the data are reported as means ± SEM.

Immunohistochemistry and immunofluorescence

The detailed methods of immunostaining for active caspase-3, active caspase-8, γ-H2AX, phospho-RPA32, p21, and double staining of phospho-H3/γ-H2AX, Ki67/γ-H2AX, pan-cytokeratin/TUNEL, and phospho-RPA32/Ki67 are described in the Supplementary Material.

Statistical analysis

Comparisons of the responses were analyzed by 1-way ANOVA and Dunnett's post hoc test using GraphPad Prism 4 software. The survival data were analyzed by log-rank test using GraphPad Prism 4 software. Differences were considered significant if the probability of the difference occurring by chance was less than 5 in 100 (P < 0.05).

Results

Loss of p53 or p21 leads to shortened survival but early crypt regeneration

Deficiencies in p53, PUMA, and p21 have been reported to alter survival following irradiation at doses causing GI syndrome and death in mice (9, 20, 28). These experiments were not always conducted in the same genetic background and used varying doses and delivery rates. To better understand the role of p53 and a possible genetic interaction of PUMA and p21 in radiation-induced GI damage, we generated cohorts of mice that were WT or deficient in p53, PUMA, p21, or PUMA and p21 (PUMA/p21 DKO) in the C57/B6 background and compared their survival following 15 Gy WBI (Fig. 1A). WT mice survived an average of 7.4 days, whereas p53 KO mice survived an average of 4.5 days, PUMA KO mice survived an average of 10.6 days, p21 KO mice survived an average of 6.5 days, and PUMA/p21 DKO survived an average of 6.3 days (Fig. 1B; ref. 20).

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

p53 or p21 deficiency led to accelerated death and crypt regeneration following WBI. A, validation of mice genotypes by PCR (left) and Western blotting using intestinal mucosal extracts 24 hours after irradiation (right). B, the survival of WT, PUMA KO, p21 KO, PUMA/p21 DKO, and p53 KO mice following 15 Gy WBI. PUMA KO versus WT, P < 0.0001; DKO versus WT, P = 0.0174; p21 KO versus WT, P = 0.0405; and p53 KO versus WT, P < 0.0001. C, mice with indicated genotypes were treated with 15 Gy WBI and received 100 mg/kg BrdU by i.p. injection 2 hours before sacrifice. Representative images of regenerated crypts identified by BrdU staining (brown) after 72 hours (magnification × 100). D, quantitation of regenerated crypts 72 hours after irradiation in mice with the indicated genotypes from 6 to 8 complete circumferences. Values are means ± SEM; n = 3 or more in each group. **, P < 0.01 compared with WT.

Surprisingly, PUMA deficiency failed to extend the survival of p21 KO mice. We have shown earlier that PUMA, but not p53, deficiency improved survival and crypt regeneration 96 hours after irradiation, whereas both blocked apoptosis by 24 hours (20). We therefore determined the timing and extent of crypt regeneration, using a microcolony assay that monitors the regeneration of single clonogenic cells following irradiation (1). We found that p53 KO, p21 KO, and PUMA/p21 DKO mice all displayed many regenerated crypts 72 hours after irradiation whereas WT and PUMA KO mice had few or none (Fig. 1C and D and Supplementary Fig. S1A). No regenerated crypt was found at 48 hours in any genotype (data not shown; ref. 20). By 96 hours, all groups of mice had regenerated crypts, with PUMA KO mice displaying the greatest amount (Supplementary Fig. S1B and C). Our results indicate that early crypt regeneration is associated with shortened survival following irradiation, suggesting that cell loss might occur in regenerated crypts via a PUMA-independent or nonapoptotic mechanism.

p53 or p21 deficiency leads to delayed nonapoptotic cell death in the intestinal crypts

We first looked for evidence of cell death by TUNEL in the intestinal crypts. The levels of TUNEL-positive cells remained elevated in p53 KO, p21 KO, and PUMA/p21 DKO mice, whereas sharply decreased in WT and PUMA KO mice 72 hours after irradiation (Fig. 2A and B and Supplementary Fig. S2A). However, the levels of active caspase-3 or caspase-8, markers for apoptosis, were very low and not significantly different among all 5 groups 72 hours after irradiation (Fig. 2B and Supplementary Fig. S3A). More TUNEL-positive cells were also observed in the crypts of p53 KO, p21 KO, and PUMA/p21 DKO mice 48 hours after irradiation (Supplementary Fig. S2B and C), suggesting extensive nonapoptotic cell death in these otherwise “normal” appearing crypts. Using an epithelial marker pan-cytokeratin, we confirmed that this caspase-independent cell death is largely confined in the intestinal epithelium (Fig. 2C and Supplementary Fig. S3B). To better understand the nature of this cell death, we compared TUNEL and active caspase-3 signals in p21 KO and WT mice at 0, 4, 24, 48, 72, and 96 hours after irradiation (Supplementary Fig. S4A and B). TUNEL signals stayed elevated in p21 KO mice at 48 hours and later but diminished in WT mice, whereas active caspase-3 signals peaked at 4 hours and gradually decreased to a minimum at 72 hours similarly in both groups (Fig. 2D and Supplementary Fig. S4A and B). Caspase-8 was also activated by radiation but declined sharply in both WT and p21 KO crypts from 48 to 72 hours (Supplementary Fig. S4C). Activate caspase-8 signals were less than 0.15 cell per crypt in unirradiated WT or p21 KO mice (data not shown). Therefore, loss of p21 led to elevated nonapoptotic cell death in the crypts 48 hours or later after irradiation during the regeneration phase (Fig. 2D).

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

p53 or p21 deficiency led to nonapoptotic cell death in the crypts following irradiation. A, mice with the indicated genotypes were treated with 15 Gy WBI and sacrificed at 72 hours. Cell death in the crypts was assessed by TUNEL and active caspase-3 staining. Representative images are shown (magnification × 400). B, TUNEL-positive or active caspase-3–positive cells were counted in 10 400× fields. When crypt structure was largely absent, the area below the villi was considered to be the crypt region. Values are means ± SEM; n = 3 in each group. **, P < 0.01 compared with WT. C, representative images and quantification of double immunofluorescent staining for TUNEL (green) and pan-cytokeratin (red) 72 hours after 15 Gy (magnification × 400). Values are means ± SEM; n = 3 in each group. **, P < 0.01 compared with WT. D, quantitation (positive cells/400× field) of active caspase-3 (Cas3*, left) and TUNEL (right) in the crypts of WT and p21 KO mice at 0, 4, 24, 48, 72, and 96 hours after 15 Gy. Values are means; n = 3 in each group.

Cell death in the crypts within 24 hours of irradiation is largely attributed to p53-dependent apoptosis through PUMA induction (1, 20). To rule out a potential impact of p21 deficiency on apoptosis, we compared TUNEL and active caspase-3 staining in the crypts of all 5 groups of mice. p53 KO, PUMA KO, and PUMA/p21 DKO mice were largely protected from apoptosis as expected (Fig. 3). Contrary to a recent study (29), our data suggest that accelerated crypt regeneration in p21 KO mice does not indicate enhanced survival of the stem cells, nor is correlated with better survival (3). The failure of PUMA deficiency to rescue early crypt regeneration and shortened survival of p21 KO mice (Fig. 1), suggesting that a p21-dependent mechanism, independent of apoptosis, must explain the differences between p53 KO and PUMA KO mice.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

p21 deficiency did not affect PUMA-dependent crypt apoptosis induced by irradiation. Mice with the indicated genotypes were treated with 15 Gy WBI and sacrificed after 4 and 24 hours. Apoptosis was analyzed by TUNEL and active caspase-3 staining. A, representative images of TUNEL immunofluorescent staining in the crypts (magnification × 600). B, quantitation of TUNEL-positive cells by counting at least 100 crypts. Values are means ± SEM; n = 3 in each group. *, P < 0.05; **, P < 0.01 compared with WT. C, representative images of active caspase-3 staining in the crypts (magnification × 600). D, quantitation of caspase-3–positive cells by counting at least 100 crypts. Values are means ± SEM; n = 3 in each group. **, P < 0.01 compared with WT.

The p21-dependent checkpoint and DNA repair in the intestinal crypts after irradiation

Given the established role of p21 in DNA damage–induced checkpoints, we carried out a 2-hour BrdU pulse experiment to monitor S-phase entry in the intestinal crypts after irradiation. DNA synthesis decreased significantly 4 hours after 15 Gy in the WT and PUMA KO (p21-competent) groups but not in the p21- or p53-deficient groups, indicating a failure of G1 checkpoint activation (Fig. 4A). Basal crypt proliferation was similar in all groups (Fig. 4A). By 24 hours after irradiation, the rate of DNA synthesis decreased in all groups, with the p53 KO group maintaining the highest level. In contrast, only a slightly higher rate of DNA synthesis was found in PUMA KO crypts, compared with WT crypts, despite blocked apoptosis (Figs. 3 and 4A).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

p21 deficiency compromised IR-induced G1/S checkpoint and DNA repair in the intestinal crypts. Mice with the indicated genotypes were treated with 15 Gy WBI and sacrificed at indicated times. A, proliferation in the intestinal crypts 0, 4, or 24 hours after irradiation was assessed by BrdU staining. Top, representative images are shown (magnification × 400). Bottom, quantitation of BrdU-positive cells from at least 100 crypts. Values are means ± SEM; n = 3 in each group. *, P < 0.05; **, P < 0.01 compared with WT at the same time point; #, P < 0.01 compared with WT 0 hours. B, representative images of γ-H2AX foci in the crypts of WT and PUMA KO mice 4 hours after irradiation (magnification × 400). C, quantitation of γ-H2AX foci in the crypts of WT and PUMA KO mice at 0, 0.5, 1, 2, 4, and 24 hours post-IR, time points not drawn in scale. Values are means; n = 3 in each group. D, quantitation of nuclear p21 expressing cells in 100 intestinal crypts from WT and PUMA KO mice at 0 (ctrl), 4, 24, and 48 hours after irradiation. Values are means ± SEM; n = 3 in each group. ***, P < 0.001 compared with WT.

We reasoned that elevated p21 (Fig. 1A; ref. 20) might facilitate DNA repair and subsequent crypt regeneration by restricting DNA synthesis immediately after irradiation in PUMA KO mice (Fig. 4A) and measured DNA double-strand breaks by γ-H2AX staining in the crypts (Fig. 4B). In the PUMA KO group, γ-H2AX foci peaked within 1 hour, sharply decreased by 2 to 4 hours. In comparison, γ-H2AX foci peaked around 4 hours in the WT group, coincident with extensive apoptosis (Fig. 4C). From 4 to 24 hours, γ-H2AX foci decreased 22% (1.16 to 0.9 per crypt) in the WT group with significant apoptosis but decreased by more than 62% (0.8 to 0.5 per crypt) in the PUMA KO group with blocked apoptosis (Figs. 4C and 3). Elevated p21 expression in the PUMA KO crypts was detected in the stem (crypt base columnar; CBC) and progenitor (+4–9) cells as early as 4 hours after irradiation (Fig. 4D and Supplementary Fig. S6). These findings suggest that p21 is required for radiation-induced checkpoint activation and DNA repair in the crypts.

p53 or p21 deficiency leads to persistent DNA damage following proliferation

Defective checkpoints and DNA repair are predicted to lead to accumulation of DNA damage and nonapoptotic death in regenerated crypts resulting from unusually rapid rounds of cell division and DNA replication (1). Concurrent with the transition from apoptotic to nonapoptotic cell death between 48 and 72 hours after irradiation, significantly more double-strand breaks were found in p21 KO, PUMA/p21 DKO, and p53 KO crypts. Approximately, 30-fold more cells inappropriately progressed through S phase and mitosis in these 3 groups, compared with the WT or PUMA KO group (Fig. 5A and B and Supplementary Fig. S7). Unrepaired double-strand breaks in S phase are known to cause stalled DNA replication forks and cell death if not resolved (4). Consistent with this prediction, the number of cells labeled with phospho-RPA32, a marker for stalled replication forks, increased by more than 6-fold in p21- and p53-deficient mice, with many coexpressing Ki67. Fewer phospho-RPA32–positive cells were observed in the PUMA KO group than other groups (Fig. 5C and D), consistent with enhanced DNA repair (Fig. 4C). These results indicate that p53-dependent p21 induction prevents accumulation of DNA damage in the intestinal crypts following irradiation.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

p53 or p21 deficiency led to compromised G2/M checkpoint, replication stress, and persistent DNA damage in the intestinal crypts following irradiation. Mice with the indicated genotypes were treated with 15 Gy WBI and sacrificed at 48 and 72 hours. Cell proliferation and mitosis were analyzed by Ki67 and phospho-H3 (pH3) staining, respectively. The presence of DNA double-strand breaks and single-stranded DNA at the replication forks were analyzed by phospho–γ-H2AX (γ-H2AX) and phospho-RPA32 (p-RPA32), respectively. A, quantitation of γ-H2AX and Ki67 double-positive cells at 48 and 72 hours after irradiation from 10 400× fields in the area below the villus. B, quantitation of double γ-H2AX- and pH3-positive cells at 48 and 72 hours after irradiation from 10 400× fields in the area below the villus. C, representative photographs of double immunofluorescent staining for p-RPA32 and Ki67 (magnification × 400). Dashed circles indicate cells stained positive for both markers. D, quantification of p-RPA32 (top) or p-RPA32/Ki67 double-positive cells (bottom), as in C. Values are means ± SEM; n = 3 in each group. **, P < 0.01 compared with WT. DAPI, 4′, 6-diamidino-2-phenylindole.

p53 or p21 deficiency leads to aberrant mitoses and severe genome instability

Loss of p53 was previously shown to increase “mitotic death” in the crypts 24 hours or later after irradiation (30). We reasoned that this “delayed” cell death can manifest as aberrant mitoses due to persistent DNA lesions coupled with cell division. Mitosis was suppressed by 60% to 70% in WT crypts 24 hours after irradiation, and more than two thirds of those seen were abnormal (Fig. 6A and B). Substantially more mitoses, including 10-fold more abnormal mitoses, were observed in p21- or p53-deficient crypts, consistent with loss of the G2/M checkpoint (Fig. 6A and B). Common abnormalities included lagging or misaligned chromosomes, anaphase bridges, multipolar spindles and micronuclei (Supplementary Fig. S8A). Mitosis was completely suppressed 48 hours after irradiation in all 5 groups of mice before crypt regeneration (data not shown). At 72 hours, significantly more aberrant mitoses were found in the regenerated crypts of p53- or p21-deficient groups compared with the WT or PUMA KO groups, which were dominated by numerous micronuclei indicative of severe genome instability (Fig. 6C and Supplementary Fig. S8B). These results suggest that “mitotic catastrophe,” characteristic of the p21- or p53-deficient crypt cells following irradiation, is a form of nonapoptotic cell death, attributable to proliferation with persistent DNA damage.

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

p53 or p21 deficiency increased aberrant mitoses and genome instability in the intestinal crypts after irradiation. Mice with the indicated genotypes were treated with 15 Gy WBI and sacrificed at the indicated times. Mitoses were analyzed on H&E-stained sections. A, examples of normal and aberrant mitoses before or 24 hours after irradiation (magnification × 600) are indicated by an arrow and asterisks, respectively. B, quantitation of normal and aberrant mitoses by counting at least 100 crypts before or 24 hours after irradiation. Values are means ± SEM; n = 3 in each group. *, P < 0.05; **, P < 0.01 compared with WT. C, quantitation of aberrant mitoses in 20 regenerated crypts 72 hours after irradiation. Values are means ± SEM; n = 3 in each group. **, P < 0.01 compared with WT. D, a model of p53-mediated responses in IR-induced intestinal damage and protection. PUMA deficiency coupled with p21 induction but not p53 deficiency, facilitates intestinal stem cell (ISC) survival and regeneration. The p21-dependent mechanisms suppress genome instability and nonapoptotic cell death following radiation.

Discussion

The role of p53 in tissue protection is complex but not well understood. Using mice deficient in p53, PUMA, p21, or PUMA and p21 (PUMA/p21 DKO), we showed that a paradoxical role of p53 in radiation-induced GI damage can be uncoupled largely through its transcriptional targets PUMA and p21. Induction of PUMA leads to rapid loss of intestinal stem cells and progenitors through apoptosis (20), and induction of p21 suppresses catastrophic regeneration of these cells by facilitating cell-cycle arrest and DNA repair. As a result, PUMA/p21 DKO mice phenocopy p53 KO mice, with blocked apoptosis but exacerbated GI damage (Fig. 6D). In contrast, p53 protects against chronic intestinal degeneration caused by telomere dysfunction by removing chromosomal-unstable stem cells perhaps through apoptosis, independent of p21 (31, 32). It appears that a dual, and sometimes paradoxical, role of p53 in tissue protection is selectively mediated by its targets, which is influenced by the proliferation demand in a given tissue, stem or progenitor cell reserves, and the extent and nature of the damage. A better understanding of these mechanisms can help protect or heal ailing tissues.

Epithelial damage appears to be the major culprit in acute GI radiation toxicity that involves both apoptotic and less understood nonapoptotic cell death (1, 9, 20, 28). Our data indicate that a failure of both the G1 and G2/M checkpoints in p21- and p53-deficient mice contributes to persistent DNA damage, massive replication stress, rampant mitotic defects, and culminates in early crypt regeneration but widespread nonapoptotic cell death. Earlier studies also reported that loss of p21 increases sensitivity to radiation or DNA damage through induction of cell death or senescence depending on the context (17, 26, 33, 34). Cell death induced by radiation appears to be more important in the intestinal epithelium, which is associated with increased proliferation or aberrant mitosis (17, 34, 35). Similarly, loss of the CDK inhibitor p27 leads to a defective G2/M checkpoint and increases genetic instability in the intestinal crypts following DNA damage (36). Deregulation of additional p53 targets might explain the more severe intestinal damage in p53 KO mice than p21 KO mice. Moreover, deficiency in DNA repair proteins ATM (ataxia telangiectasia mutated; ref. 37), p53BP1 (38), or PARP-1 (39) exacerbates radiation-induced crypt damage in mice, supporting the notion that DNA repair is critical for productive intestinal regeneration by suppressing genomic instability and nonapoptotic cell death.

Subpools of stem cells were recently proposed to be responsible for normal maintenance or regeneration following injury in rapidly renewing tissues including the GI tract (40). The apoptosis-dependent and -independent mechanisms of p53 have been shown to be differentially regulated in hematopoietic stem and progenitor cells following irradiation (41, 42). Our earlier work showed that PUMA deficiency provided a better protection against IR-induced apoptosis in the CBCs (43), compared with p53 deficiency (27), consistent with the rapidly renewing CBCs contributing to crypt regeneration (data not shown). It is possible that intestinal stem cells and progenitors might utilize different components of the DNA damage response machinery in response to irradiation or other cytotoxic agents. Well-defined intestinal stem cell markers and mouse models will help provide a deeper understanding of p53-mediated DNA damage responses important in GI diseases including cancer.

There is currently no effective countermeasure against acute GI damage induced by radiation, and targeting p53 carries a high risk for cancer and is unlikely to be useful in this system (10, 44). Our studies suggest a potential strategy, blocking PUMA-dependent apoptosis helps preserve the stem and progenitor compartments immediately after irradiation, whereas enhanced DNA repair and genome stability, at least in part via p21, can further aid their productive regeneration (Fig. 6D). A number of recent studies support this notion. Blocking PUMA-dependent apoptosis profoundly protects against IR-induced GI and HP damage (20–23) or adult stem cell depletion on p53 activation (45) but carries little risk for spontaneous tumorigenesis and even suppresses IR-induced lymphoma (24, 46–48). Small molecule PUMA inhibitors are being developed for radiation and mitigation (49), whereas small molecule CDK4/6 inhibitors suppressed radiation toxicity in the HP system (50). It would be interesting to see whether these molecules can work together to protect normal tissues against radiation or chemotherapy-induced injury. In addition, activation of nonapoptotic cell death pathways might be exploited in p53-negative tumors to improve the efficacy of radiation or chemotherapy through selective killing of tumor cells (51). Therefore, manipulating PUMA and p21, as opposed to p53, might hold a greater promise in clinical settings by balancing short-term tissue reconstitution and long-term cancer risk (Fig. 6D).

Disclosure of Potential Conflicts of Interest

No potential conflicts of interest were disclosed.

Grant Support

This work is supported in part by NIH grants UO1-DK085570 (J. Yu, T. Cheng, and L. Zhang), NIH (U19A1068021 Pilot to J. Yu), CA129829 (J. Yu), CA106348 (L. Zhang, J. Yu), CA121105 (L. Zhang), AI080424 (T. Cheng), and American Cancer Society grants RGS-10-124-01-CCE (J. Yu) and RGS-07-156-01-CNE (L. Zhang). The UO1 grant is part of the Intestinal Stem Cell Consortium, a collaborative research project funded by the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of Allergy and Infectious Diseases.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Acknowledgments

The authors thank Drs. Monica Buchanan and Crissy Dudgeon for critical reading.

B.J. Leibowitz designed and conducted experiments, analyzed data, and wrote the manuscript; W. Qiu and H. Liu conducted experiments and analyzed data; T. Cheng and L. Zhang provided key reagents and analyzed data; and J. Yu designed experiments, analyzed data, and wrote the manuscript.

Footnotes

  • Note: Supplementary data for this article are available at Molecular Cancer Research Online (http://mcr.aacrjournals.org/).

  • Received January 28, 2011.
  • Revision received March 15, 2011.
  • Accepted March 17, 2011.
  • ©2011 American Association for Cancer Research.

References

  1. 1.↵
    1. Potten CS
    . Radiation, the ideal cytotoxic agent for studying the cell biology of tissues such as the small intestine. Radiat Res 2004; 161: 123–36.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Greenberger JS
    . Radioprotection. In Vivo 2009; 23: 323–36.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Terry NH,
    2. Travis EL
    . The influence of bone marrow depletion on intestinal radiation damage. Int J Radiat Oncol Biol Phys 1989; 17: 569–73.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Harper JW,
    2. Elledge SJ
    . The DNA damage response: ten years after. Mol Cell 2007; 28: 739–45.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Weissman IL
    . Stem cells: units of development, units of regeneration, and units in evolution. Cell 2000; 100: 157–68.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Westphal CH,
    2. Rowan S,
    3. Schmaltz C,
    4. Elson A,
    5. Fisher DE,
    6. Leder P
    . atm and p53 cooperate in apoptosis and suppression of tumorigenesis, but not in resistance to acute radiation toxicity. Nat Genet 1997; 16: 397–401.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Botchkarev VA,
    2. Komarova EA,
    3. Siebenhaar F,
    4. Botchkareva NV,
    5. Komarov PG,
    6. Maurer M,
    7. et al.
    p53 is essential for chemotherapy-induced hair loss. Cancer Res 2000; 60: 5002–6.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Merritt AJ,
    2. Potten CS,
    3. Kemp CJ,
    4. Hickman JA,
    5. Balmain A,
    6. Lane DP,
    7. et al.
    The role of p53 in spontaneous and radiation-induced apoptosis in the gastrointestinal tract of normal and p53-deficient mice. Cancer Res 1994; 54: 614–7.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Komarova EA,
    2. Kondratov RV,
    3. Wang K,
    4. Christov K,
    5. Golovkina TV,
    6. Goldblum JR,
    7. et al.
    Dual effect of p53 on radiation sensitivity in vivo: p53 promotes hematopoietic injury, but protects from gastro-intestinal syndrome in mice. Oncogene 2004; 23: 3265–71.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Gudkov AV,
    2. Komarova EA
    . The role of p53 in determining sensitivity to radiotherapy. Nat Rev Cancer 2003; 3: 117–29.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Vogelstein B,
    2. Lane D,
    3. Levine AJ
    . Surfing the p53 network. Nature 2000; 408: 307–10.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Vousden KH,
    2. Prives C
    . Blinded by the light: the growing complexity of p53. Cell 2009; 137: 413–31.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Yu J,
    2. Zhang L
    . The transcriptional targets of p53 in apoptosis control. Biochem Biophys Res Commun 2005; 331: 851–8.
    OpenUrlCrossRefPubMed
  14. 14.↵
    1. Sherr CJ,
    2. Roberts JM
    . CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13: 1501–12.
    OpenUrlFREE Full Text
  15. 15.↵
    1. Yu J,
    2. Zhang L,
    3. Hwang PM,
    4. Kinzler KW,
    5. Vogelstein B
    . PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 2001; 7: 673–82.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Nakano K,
    2. Vousden KH
    . PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 2001; 7: 683–94.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Yu J,
    2. Wang Z,
    3. Kinzler KW,
    4. Vogelstein B,
    5. Zhang L
    . PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci U S A 2003; 100: 1931–6.
    OpenUrlAbstract/FREE Full Text
  18. 18.↵
    1. Ming L,
    2. Wang P,
    3. Bank A,
    4. Yu J,
    5. Zhang L
    . PUMA dissociates Bax and BCL-XL to induce apoptosis in colon cancer cells. J Biol Chem 2006; 281: 16034–42.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Yu J,
    2. Zhang L
    . PUMA, a potent killer with or without p53. Oncogene 2008; 27 Suppl 1: S71–83.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Qiu W,
    2. Carson-Walter EB,
    3. Liu H,
    4. Epperly M,
    5. Greenberger JS,
    6. Zambetti GP,
    7. et al.
    PUMA regulates intestinal progenitor cell radiosensitivity and gastrointestinal syndrome. Cell Stem Cell 2008; 2: 576–83.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Wu WS,
    2. Heinrichs S,
    3. Xu D,
    4. Garrison SP,
    5. Zambetti GP,
    6. Adams JM,
    7. et al.
    Slug antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing puma. Cell 2005; 123: 641–53.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Yu H,
    2. Shen H,
    3. Yuan Y,
    4. XuFeng R,
    5. Hu X,
    6. Garrison SP,
    7. et al.
    Deletion of Puma protects hematopoietic stem cells and confers long-term survival in response to high-dose gamma-irradiation. Blood 2010; 115: 3472–80.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Shao L,
    2. Sun Y,
    3. Zhang Z,
    4. Feng W,
    5. Gao Y,
    6. Cai Z,
    7. et al.
    Deletion of proapoptotic Puma selectively protects hematopoietic stem and progenitor cells against high-dose radiation. Blood 2010; 115: 4707–14.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Jeffers JR,
    2. Parganas E,
    3. Lee Y,
    4. Yang C,
    5. Wang J,
    6. Brennan J,
    7. et al.
    Puma is an essential mediator of p53-dependent and -independent apoptotic pathways. Cancer Cell 2003; 4: 321–8.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Wu B,
    2. Qiu W,
    3. Wang P,
    4. Yu H,
    5. Cheng T,
    6. Zambetti GP,
    7. et al.
    p53 independent induction of PUMA mediates intestinal apoptosis in response to ischaemia-reperfusion. Gut 2007; 56: 645–54.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Cheng T,
    2. Rodrigues N,
    3. Shen H,
    4. Yang Y,
    5. Dombkowski D,
    6. Sykes M,
    7. et al.
    Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 2000; 287: 1804–8.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Qiu W,
    2. Leibowitz B,
    3. Zhang L,
    4. Yu J
    . Growth factors protect intestinal stem cells from radiation-induced apoptosis by suppressing PUMA through the PI3K/AKT/p53 axis. Oncogene 2009; 29: 1622–32.
    OpenUrlPubMed
  28. 28.↵
    1. Kirsch DG,
    2. Santiago PM,
    3. di Tomaso E,
    4. Sullivan JM,
    5. Hou WS,
    6. Dayton T,
    7. et al.
    p53 controls radiation-induced gastrointestinal syndrome in mice independent of apoptosis. Science 2010; 327: 593–6.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. George RJ,
    2. Sturmoski MA,
    3. May R,
    4. Sureban SM,
    5. Dieckgraefe BK,
    6. Anant S,
    7. et al.
    Loss of p21Waf1/Cip1/Sdi1 enhances intestinal stem cell survival following radiation injury. Am J Physiol Gastrointest Liver Physiol 2009; 296: G245–54.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Merritt AJ,
    2. Allen TD,
    3. Potten CS,
    4. Hickman JA
    . Apoptosis in small intestinal epithelial from p53-null mice: evidence for a delayed, p53-independent G2/M-associated cell death after gamma-irradiation. Oncogene 1997; 14: 2759–66.
    OpenUrlCrossRefPubMed
  31. 31.↵
    1. Begus-Nahrmann Y,
    2. Lechel A,
    3. Obenauf AC,
    4. Nalapareddy K,
    5. Peit E,
    6. Hoffmann E,
    7. et al.
    p53 deletion impairs clearance of chromosomal-instable stem cells in aging telomere-dysfunctional mice. Nat Genet 2009; 41: 1138–43.
    OpenUrlCrossRefPubMed
  32. 32.↵
    1. Choudhury AR,
    2. Ju Z,
    3. Djojosubroto MW,
    4. Schienke A,
    5. Lechel A,
    6. Schaetzlein S,
    7. et al.
    Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation. Nat Genet 2007; 39: 99–105.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Wang YA,
    2. Elson A,
    3. Leder P
    . Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice. Proc Natl Acad Sci U S A 1997; 94: 14590–5.
    OpenUrlAbstract/FREE Full Text
  34. 34.↵
    1. Komarova EA,
    2. Christov K,
    3. Faerman AI,
    4. Gudkov AV
    . Different impact of p53 and p21 on the radiation response of mouse tissues. Oncogene 2000; 19: 3791–8.
    OpenUrlCrossRefPubMed
  35. 35.↵
    1. Waldman T,
    2. Lengauer C,
    3. Kinzler KW,
    4. Vogelstein B
    . Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21. Nature 1996; 381: 713–16.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Payne SR,
    2. Zhang S,
    3. Tsuchiya K,
    4. Moser R,
    5. Gurley KE,
    6. Longton G,
    7. et al.
    p27kip1 deficiency impairs G2/M arrest in response to DNA damage, leading to an increase in genetic instability. Mol Cell Biol 2008; 28: 258–68.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Ch'ang HJ,
    2. Maj JG,
    3. Paris F,
    4. Xing HR,
    5. Zhang J,
    6. Truman JP,
    7. et al.
    ATM regulates target switching to escalating doses of radiation in the intestines. Nat Med 2005; 11: 484–90.
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Clarke AR,
    2. Jones N,
    3. Pryde F,
    4. Adachi Y,
    5. Sansom OJ
    . 53BP1 deficiency in intestinal enterocytes does not alter the immediate response to ionizing radiation, but leads to increased nuclear area consistent with polyploidy. Oncogene 2007; 26: 6349–55.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Ishizuka S,
    2. Martin K,
    3. Booth C,
    4. Potten CS,
    5. de Murcia G,
    6. Bürkle A,
    7. et al.
    Poly(ADP-ribose) polymerase-1 is a survival factor for radiation-exposed intestinal epithelial stem cells in vivo. Nucleic Acids Res 2003; 31: 6198–205.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Li L,
    2. Clevers H
    . Coexistence of quiescent and active adult stem cells in mammals. Science 2010; 327: 542–5.
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    1. Mohrin M,
    2. Bourke E,
    3. Alexander D,
    4. Warr MR,
    5. Barry-Holson K,
    6. Le Beau MM,
    7. et al.
    Hematopoietic stem cell quiescence promotes error-prone DNA repair and mutagenesis. Cell Stem Cell 2010; 7: 174–85.
    OpenUrlCrossRefPubMed
  42. 42.↵
    1. Milyavsky M,
    2. Gan OI,
    3. Trottier M,
    4. Komosa M,
    5. Tabach O,
    6. Notta F,
    7. et al.
    A distinctive DNA damage response in human hematopoietic stem cells reveals an apoptosis-independent role for p53 in self-renewal. Cell Stem Cell 2010; 7: 186–97.
    OpenUrlCrossRefPubMed
  43. 43.↵
    1. Barker N,
    2. van Es JH,
    3. Kuipers J,
    4. Kujala P,
    5. van den Born M,
    6. Cozijnsen M,
    7. et al.
    Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007; 449: 1003–7.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Donehower LA,
    2. Harvey M,
    3. Slagle BL,
    4. McArthur MJ,
    5. Montgomery CA,
    6. Butel JS,
    7. et al.
    Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356: 215–21.
    OpenUrlCrossRefPubMed
  45. 45.↵
    1. Liu D,
    2. Ou L,
    3. Clemenson GD Jr,
    4. Chao C,
    5. Lutske ME,
    6. Zambetti GP,
    7. et al.
    Puma is required for p53-induced depletion of adult stem cells. Nat Cell Biol 2010; 12: 993–8.
    OpenUrlCrossRefPubMed
  46. 46.↵
    1. Villunger A,
    2. Michalak EM,
    3. Coultas L,
    4. Müllauer F,
    5. Böck G,
    6. Ausserlechner MJ,
    7. et al.
    p53- and Drug-Induced Apoptotic Responses Mediated by BH3-Only Proteins Puma and Noxa. Science 2003; 302: 1036–8.
    OpenUrlAbstract/FREE Full Text
  47. 47.↵
    1. Michalak EM,
    2. Vandenberg CJ,
    3. Delbridge AR,
    4. Wu L,
    5. Scott CL,
    6. Adams JM,
    7. et al.
    Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death. Genes Dev 2010; 24: 1608–13.
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    1. Labi V,
    2. Erlacher M,
    3. Krumschnabel G,
    4. Manzl C,
    5. Tzankov A,
    6. Pinon J,
    7. et al.
    Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation. Genes Dev 20101; 24: 1602–7.
    OpenUrlAbstract/FREE Full Text
  49. 49.↵
    1. Mustata G,
    2. Li M,
    3. Zevola N,
    4. Bakan A,
    5. Zhang L,
    6. Epperly M,
    7. et al.
    Development of small-molecule PUMA inhibitors for mitigating radiation-induced cell death. Curr Top Med Chem 2011; 11: 281–90.
    OpenUrlPubMed
  50. 50.↵
    1. Johnson SM,
    2. Torrice CD,
    3. Bell JF,
    4. Monahan KB,
    5. Jiang Q,
    6. Wang Y,
    7. et al.
    Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition. J Clin Invest 2010; 120: 2528–36.
    OpenUrlCrossRefPubMed
  51. 51.↵
    1. Finkel E
    . Does cancer therapy trigger cell suicide? Science 1999; 286: 2256–8.
    OpenUrlFREE Full Text
PreviousNext
Back to top
Molecular Cancer Research: 9 (5)
May 2011
Volume 9, Issue 5
  • Table of Contents
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Uncoupling p53 Functions in Radiation-Induced Intestinal Damage via PUMA and p21
(Your Name) has forwarded a page to you from Molecular Cancer Research
(Your Name) thought you would be interested in this article in Molecular Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Uncoupling p53 Functions in Radiation-Induced Intestinal Damage via PUMA and p21
Brian J. Leibowitz, Wei Qiu, Hongtao Liu, Tao Cheng, Lin Zhang and Jian Yu
Mol Cancer Res May 1 2011 (9) (5) 616-625; DOI: 10.1158/1541-7786.MCR-11-0052

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Uncoupling p53 Functions in Radiation-Induced Intestinal Damage via PUMA and p21
Brian J. Leibowitz, Wei Qiu, Hongtao Liu, Tao Cheng, Lin Zhang and Jian Yu
Mol Cancer Res May 1 2011 (9) (5) 616-625; DOI: 10.1158/1541-7786.MCR-11-0052
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Grant Support
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • A Cross-species Alkylation Functionome
  • Radiation-Induced EGFR-DNA-PKcs Interactions
  • Suberoylanilide Hydroxamic Acid Inhibits Homolog-Directed Repair
Show more DNA Damage and Cellular Stress Responses
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Rapid Impact Archive
  • Meeting Abstracts

Information for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCR

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Research
eISSN: 1557-3125
ISSN: 1541-7786

Advertisement